TP53 and large cell neuroendocrine carcinoma: A recent study identified co-alterations of TP53 and RB1 in 86% of SCNEC and in 50% of LCNEC, while 100% of the SCNEC and 50% of the LCNEC cases that were studied showed RB loss [100].